Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar
Clinical trial NCT07077681 · RECRUITING
Trial details
- NCT number
- NCT07077681
- Sponsor
- EG Labo
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-02
- Primary completion
- 2026-04-30
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.